These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27734565)

  • 1. Polyglutamine toxicity in yeast uncovers phenotypic variations between different fluorescent protein fusions.
    Jiang Y; Di Gregorio SE; Duennwald ML; Lajoie P
    Traffic; 2017 Jan; 18(1):58-70. PubMed ID: 27734565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyglutamine toxicity assays highlight the advantages of mScarlet for imaging in
    Albakri MB; Jiang Y; Genereaux J; Lajoie P
    F1000Res; 2018; 7():1242. PubMed ID: 30631438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fluorescent Proteins on Fusion Partners Using Polyglutamine Toxicity Assays in Yeast.
    Jiang Y; Di Gregorio S; Albakri MB; Duennwald ML; Lajoie P
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30582582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.
    Meriin AB; Zhang X; He X; Newnam GP; Chernoff YO; Sherman MY
    J Cell Biol; 2002 Jun; 157(6):997-1004. PubMed ID: 12058016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases.
    Alexandrov AI; Serpionov GV; Kushnirov VV; Ter-Avanesyan MD
    Prion; 2016 May; 10(3):221-7. PubMed ID: 27220690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML
    Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis.
    Ocampo A; Zambrano A; Barrientos A
    FASEB J; 2010 May; 24(5):1431-41. PubMed ID: 20008543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast as a platform to explore polyglutamine toxicity and aggregation.
    Duennwald ML
    Methods Mol Biol; 2013; 1017():153-61. PubMed ID: 23719914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.
    Behrends C; Langer CA; Boteva R; Böttcher UM; Stemp MJ; Schaffar G; Rao BV; Giese A; Kretzschmar H; Siegers K; Hartl FU
    Mol Cell; 2006 Sep; 23(6):887-97. PubMed ID: 16973440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Mutant Huntingtin Binding Partners in Yeast Species.
    Zhao Y; Zurawel AA; Jenkins NP; Duennwald ML; Cheng C; Kettenbach AN; Supattapone S
    Sci Rep; 2018 Jun; 8(1):9554. PubMed ID: 29934597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and structural architecture of polyQ aggregates in yeast.
    Gruber A; Hornburg D; Antonin M; Krahmer N; Collado J; Schaffer M; Zubaite G; Lüchtenborg C; Sachsenheimer T; Brügger B; Mann M; Baumeister W; Hartl FU; Hipp MS; Fernández-Busnadiego R
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3446-E3453. PubMed ID: 29581260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin.
    Wang H; Lim PJ; Yin C; Rieckher M; Vogel BE; Monteiro MJ
    Hum Mol Genet; 2006 Mar; 15(6):1025-41. PubMed ID: 16461334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Plasmids for Fluorescent Protein Tagging of Microtubules in Saccharomyces cerevisiae.
    Markus SM; Omer S; Baranowski K; Lee WL
    Traffic; 2015 Jul; 16(7):773-786. PubMed ID: 25711127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.
    Sorolla MA; Nierga C; Rodríguez-Colman MJ; Reverter-Branchat G; Arenas A; Tamarit J; Ros J; Cabiscol E
    Arch Biochem Biophys; 2011 Jun; 510(1):27-34. PubMed ID: 21513696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the treatment of polyglutamine diseases: the modulatory role of protein context.
    Robertson AL; Bottomley SP
    Curr Med Chem; 2010; 17(27):3058-68. PubMed ID: 20629626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death.
    Parker JA; Connolly JB; Wellington C; Hayden M; Dausset J; Neri C
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13318-23. PubMed ID: 11687635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network of protein interactions determines polyglutamine toxicity.
    Duennwald ML; Jagadish S; Giorgini F; Muchowski PJ; Lindquist S
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11051-6. PubMed ID: 16832049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spt4 is selectively required for transcription of extended trinucleotide repeats.
    Liu CR; Chang CR; Chern Y; Wang TH; Hsieh WC; Shen WC; Chang CY; Chu IC; Deng N; Cohen SN; Cheng TH
    Cell; 2012 Feb; 148(4):690-701. PubMed ID: 22341442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions.
    Tam S; Geller R; Spiess C; Frydman J
    Nat Cell Biol; 2006 Oct; 8(10):1155-62. PubMed ID: 16980959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of an expanded polyglutamine domain in yeast causes death with apoptotic markers.
    Sokolov S; Pozniakovsky A; Bocharova N; Knorre D; Severin F
    Biochim Biophys Acta; 2006; 1757(5-6):660-6. PubMed ID: 16784720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.